phrma logo

PhRMA

PhRMA Sites

Login

Explore Member-Only Resources

Access exclusive advocacy, policy, and research materials through the member site.

Login now

About

About

Our Agenda

Our Agenda

Policy Issues

We believe that patients should have access to innovative medicines.

Learn More

Innovation Ecosystem

Intellectual Property

Research & Development

Future of Medicine

Government Price Setting

International

Innovation Ecosystem

Patient Access & Affordability

PBMs & Middlemen

Hospitals and 340B

Insurance Coverage

Cost of Medicines

Medicare & Medicaid

Patient Access & Affordability

Resources

Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies.

Learn More

Resources

Resources

Newsroom

Newsroom

Blog

Blog

America's Medicines

PhRMA Foundation

PhRMA Foundation Logo

Voters for Cures

VotersForCures.org Logo

Working for Cures

workersforcures.org logo

This is Innovation

Innovation.org logo

View More

Search in PhRMA

Find resources, news, and articles related to policy issues and scientific innovation.

What are you looking for?

Most Recent

Policy Paper

Press

Blog

Report

Fact Sheet

Event

Resource

Pages

Leader

Author

Comment

not used title

not used title

A recent Patient Experience Survey found that Americans with serious chronic conditions, including autoimmune diseases, mental health conditions and neurologic conditions were more likely than all insured Americans to report facing unaffordable out-of-pocket costs. These patients were also more likely to experience insurer-imposed barriers, like prior authorization and fail first. Accessing the medicine patients need is simply too burdensome for many Americans struggling with chronic illness.

Here are three critical health insurance challenges facing patients with chronic illnesses.

1. Insured Americans managing chronic illnesses are disproportionately likely to report challenges affording their out-of-pocket costs. A quarter of Americans with autoimmune diseases, nearly a third of patients with mental health conditions and a third of patients with neurologic conditions reported that their out-of-pocket costs were more than they could afford.

pes graph

2. Patients with chronic illnesses report face more insurer-imposed access barriers that deny or limit access to their medications. Among patients taking prescription medicines, those with autoimmune diseases (73%), mental health conditions (65%) or neurologic conditions (64%) were disproportionately likely to report facing insurance-imposed barriers, like prior authorization and fail first, compared to all patients who take prescription medicines (49%).

pes graph 2

3. Insurance practices resulting in higher out-of-pocket costs make it difficult for patients to access the medicines their doctors prescribe and disproportionately burden patients with severe and chronic conditions. Compared to all patients who take prescription medicines (51%), patients with autoimmune diseases (60%), mental health conditions (71%) and neurologic conditions (68%) were significantly more likely to report at least one time in the past 12 months when they did not take a treatment as prescribed, such as skipping doses or cutting pills in half. To address the challenges patients face accessing their care, nearly twice as many insured Americans said they would prefer paying lower out-of-pocket costs (such as copays, coinsurance and deductibles) for medicines compared to paying a lower premium each month.

Americans managing serious chronic conditions face insurance-imposed barriers that make it difficult for them to access the care they need. Policymakers should consider the patient experience when discussing health care reforms, to ensure that solutions meaningfully address the challenges patients face.

Read the full Patient Experience Survey report here. For more on PhRMA’s patient-centered solutions, visit PhRMA.org/BetterWay.

+++

PhRMA’s Patient Experience Survey is a research initiative designed to explore the barriers patients face in accessing health care and prescription medicines. Launched in the wake of the coronavirus pandemic, which exposed many of the vulnerabilities of our health care system, the survey reports the lived experiences of 5,000 Americans. Among the sample of 5,000 Americans are patients impacted by health conditions like autoimmune, blood or immune diseases, including but not limited to: anemia, celiac disease, Graves’ disease, Hashimoto's thyroiditis, hemophilia, lupus, sickle-cell anemia; mental health conditions, including but not limited to: Alzheimer’s disease, anxiety or panic disorder, bipolar disorder / manic depression, dementia, obsessive-compulsive disorder, post-traumatic stress disorder, schizophrenia; and, neurologic or nervous system conditions, including but not limited to: epilepsy/seizure disorder, amyotrophic lateral sclerosis (ALS), multiple sclerosis, Parkinson’s disease, stroke, traumatic brain injury.

Cynthia Hicks

Cynthia Hicks is Senior Director of Public Affairs at PhRMA focusing on polling and opinion research that supports advocacy communications and strategy. Prior to joining PhRMA, Cynthia worked as a consultant, marketer, and head of polling for a civic technology company where her work supported issue advocacy organizations and policy makers on both sides of the aisle. Cynthia is a proud Los Angeles native and outside of the office she enjoys an early morning HIIT workout and spending time with friends and family.

Cynthia Hicks

Survey confirms too many insured Americans face barriers to reliable health care

April 22, 2026

Insurers routinely block seniors’ access to medicines in Medicare Part D

March 18, 2026

Americans believe U.S. pharma leadership needs to be protected

February 26, 2026

50-state poll says Americans are concerned that hospital markups hurt patients

January 27, 2026

Study finds insurance barriers disproportionately burden patients with chronic illness

Health Insurance

Out-of-Pocket Costs

Polling

Study finds insurance barriers disproportionately burden patients with chronic illness

May 4, 2022

Study finds insurance barriers disproportionately burden patients with chronic illness

Stay current on policy making

Sign up for email updates and follow us on social. 

About

Our Agenda

Policy Issues

Resources

Blog

Contact Us

Privacy Policy

Terms of Service

Facebook

Facebook

X

Twitter X

LinkedIn

LinkedIn

Instagram

instagram logo

America's Medicines

PhRMA Foundation

Voters for Cures

Working for Cures

Innovation.org

Please type your email

Success!

You've been added to the list